Research Center Profile:
Cook Children's Health Care System
Cardiology/Vascular Diseases
Hematology
Immunology
Infections and Infectious Diseases
Nephrology
Neurology
Oncology
Pediatrics/Neonatology
Pulmonary/Respiratory Diseases
Urology
Mission: Cook Children's Health Care
System(CCHCS) is an integrated delivery organization dedicated to
providing quality health care and improving the well-being of
children.
Cook Children's Medical Center (CCMC), the cornerstone
component of CCHCS, is a private, 282-bed, pediatric health care
center. More than 200 board-certified or board-eligible
pediatricians, pediatric sub specialists, family practitioners, and
dentists provide services to our pediatric community. Additionally,
CCHCS currently operates 5 primary care clinics in underserved
areas of the local community, 296 primary care and specialty
pediatric practices in the local and west Texas areas, 5 specialty
care clinics in rural and/or underserved areas, and Cook
Children's Home Health. CCMC is the only tertiary
children's hospital between Fort Worth, Texas and the state of
New Mexico, encompassing over 100,000 square miles in a 110 county
area in north central and west Texas. Comprehensive health care
services are provided to children between the ages of 0 to 18
years.
CCMC provides tertiary and quaternary services in more than 35
specialty areas including nationally recognized programs for
Neonatology, Pediatric Intensive Care, Trauma, Hematology/Oncology,
Cardiology, Cardiothoracic Surgery and Pulmonology. The Bone Marrow
and Stem Cell Transplantation Program is the largest pediatric transplant program in
the state of Texas and southern United States. The Heart Center has
one of the largest cardiac surgery volumes in Texas.
CCHCS strives to promote the health and well being of children
and families in North Central Texas. This effort is enhanced by
facilitating children's' access to leading clinical
research opportunities. Since 1982, clinical therapeutic research
has been conducted primarily in the Hematology/Oncology division in
collaboration with the Children's Oncology group. However, in
recent years a growing trend toward clinical research participation
has developed throughout most CCHCS primary care and specialty
sections.
Trials have been conducted with the following industry
sponsors:
AAIPharma
Abbott Laboratories
ADMA Biologics
ADMA Pharmaceuticals
AGA Medical Corporation
Alcon
Altus Pharmaceuticals
American Thrombosis & Hemostasis Network (ATHN)
Anthera Pharmaceuticals
Arkansas Children's Hospital Research Inst (ACHRI)
AstraZeneca
Bayer
Baxter
Baylor University
Biomerieux
Brigham & Woman's Hospital
Bristol-Myers Squibb
Broad Agency Announcement (BAA)
Cangene Corporation
CASG
Cephalon, Inc.
Cerexa
CF Therapeutics Development Network
Children's Hospital of Los Angeles (CHLA)
Children's Hospital of Wisconsin
Chimerix
Cincinnati Children's Hospital
City of Hope (COH)
COG
CSL Behring
Cubist
Dell Children's Medical Center (Seton)
Diamyd
Duke University
Eisai
Eli Lily
Forest Research Institute
FS Grifols
Genentech Inc.
Gentium, S.P.A.
Genzyme
Gilead Sciences
GlaxoSmithKline
Innovacon
Ipsen
Janssen Services LLC
Johnson & Johnson
KC BioMediX
King Pharmaceuticals Research and Development, Inc.
Mayo Clinic
MD Anderson
Medical College of Wisconsin
MedImmune
Medtronic
Merck
MPEX Pharmaceuticals
NANT New Approaches to Neuroblastoma Therapy
Nestle Infant Nutrition
NMDP National Marrow Donor Program
Novartis Pharmaceutical
NovoNordisk
Ortho-McNeil Neurologics
Ovation Pharmaceuticals
Parexel International
Pediatrix
Pfizer
Proctor & Gamble Pharmaceuticals
PROS (Pediatric Research in Office Settings)
Protherics, Inc.
Roche Laboratories
Sanofi Pasteur
Sanofi Aventis
Schering-Plough
Schwarz Biosciences
Social & Scientific Systems, Inc.
St. Jude
Tercica
Texas Children's Hospital
Texas Tech
Tibotec Pharmaceuticals Ltd.
TX Pediatric Brain Tumor Consortium (TPBTC)
UCB Pharmaceutical Inc
UNC Chapel Hill
United BioSource Corp.
Univ of Buffalo
Univ of CA San Francisco
Univ of CO
Univ. of Texas at Houston
University of North Texas Health Science Center
University South Florida - Moffit Cancer Center
Upsher-Smith Laboratories
UT Southwestern Medical Center
UTHSC San Antonio
Vertex Pharmaceuticals
Warner Chilcott Pharmaceuticals
Wills Eye Institute in Philadelphia
CCMC has the ability to conduct both inpatient and outpatient
trials involving healthy children and those afflicted by virtually
all pediatric disorders using a full complement of state-of-the-art
diagnostic and therapeutic techniques. Cook Children's Medical
Center holds a Gold Seal of Approval * for hospital services from
the Joint Commission on Accreditation of Healthcare Organizations
(JCAHO). Cook Children's Medical Center received a score of 97
and is Accredited With Full Standards Compliance, August 2003. CCMC
has dedicated research pharmacists and laboratory technicians
providing optimal efficiency and accuracy.
The main hospital campus is located on the western side of the
Dallas-Fort Worth Metroplex approximately 40 minutes from the DFW
airport. Major interstate and rail lines serve the entire
region.
Cook Children's Physician Network is the largest pediatric
physician network in North Texas with approximately 250 physicians.
The network includes pediatric specialists and primary care
physicians with a varying degree of research experience.
The Research Operations Department offers an initial point of
contact for sponsors seeking study placement and assistance with
matching protocols with potential investigators.
Some therapeutic areas at CCMC have research staff dedicated to
that area. However, clinical research coordinators are also
available via the Research Operations Department (Research Administration Office) on a fee-for-service basis to provide support for
research activities in all CCHCS inpatient and outpatient
facilities and local community PCP offices. Research Operations
services include initial study placement procedures, review and
negotiation of trial budgets, preparation of IRB submission
documents, assistance with recruitment of study patients, and
completion of protocol requirements as delegated by the
Investigator. The Research Operations Department coordinators are
encouraged to obtain certification.
CCMC provides comprehensive health care services to children
between the ages of 0 to 18 years. The CCHCS referral area
encompasses over 100,000 square miles in a 110-county area in north
central and west Texas. This vast geographic area is home to more
than 1.2 million children under the age of 15. In fiscal year 2003,
CCHCS and CCMC recorded nearly 300,000 patient visits and over
8,000 hospital admissions. The demographics of the pediatric
population served was widely variable, including approximately 14%
African-American, 1% Asian, <1% American Indian, 56% Caucasian,
and 24% Hispanic. A total of 45% of Cook Children's patients
were female and 55% were males.
Cook Children's Health Care System requires all research
protocols conducted at CCHCS to receive approval by our local IRB.
The CCHCS IRB meets monthly.
Leigh Donahue, RN, MBA, CCRC
Director, Research Operations
leigh.donahue@cookchildrens.org
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the email form below. A representative from
the research center will then follow up with you.